Abstract
Purpose
Total hip arthroplasty (THA) in patients with rheumatoid arthritis (RA) has been associated with an increased risk of periprosthetic joint infection, periprosthetic fractures, dislocations, and post-operative blood transfusion. However, higher post-operative blood transfusion is unclear whether it reflects peri-operative blood loss or is characteristic of RA. This study aimed to compare the complications, allogenic blood transfusion, albumin use, and peri-operative blood loss between patients who underwent THA because of RA or osteoarthritis (OA).
Methods
Patients undergoing cementless THA for hip RA (n = 220) or hip OA (n = 261) at our hospital between 2011 and 2021 were retrospectively enrolled. Deep vein thrombosis, pulmonary embolism, myocardial infarction, calf muscular venous thrombosis, wound complications, deep prosthetic infection, hip prosthesis dislocation, periprosthetic fractures, 30-day mortality, 90-day readmission, allogeneic blood transfusion, and albumin infusions were considered as primary outcomes, while secondary outcomes included the number of perioperative anaemia patients as well as total, intra-operative, and hidden blood loss.
Results
Compared to the OA group, patients with hip RA showed significantly higher rates of wound aseptic complications, hip prosthesis dislocation, homologous transfusion, and albumin use. RA patients also showed a significantly higher prevalence of pre-operative anemia. However, no significant differences were observed between the two groups in total, intra-operative, or hidden blood loss.
Conclusions
Our study suggests that RA patients undergoing THA are at a higher risk of wound aseptic complications and hip prosthesis dislocation than patients with hip OA. Pre-operative anaemia and hypoalbuminaemia in patients with hip RA place them at a significantly higher risk of post-operative blood transfusion and use of albumin.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Świtoń A, Wodka-Natkaniec E, Niedźwiedzki Ł, Gaździk T, Niedźwiedzki T (2017) Activity and quality of life after total hip arthroplasty. Ortop Traumatol Rehabil 19:441–450
Carling MS, Jeppsson A, Eriksson BI, Brisby H (2015) Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res 10:48. https://doi.org/10.1186/s13018-015-0188-6
Zhou VY et al (2022) Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study. Rheumatology (Oxford) 61:1819–1830. https://doi.org/10.1093/rheumatology/keab643
Lee Y-H, Ko P-Y, Kao S-L, Lin M-C, Cheng-Chung Wei J (2020) Risk of total knee and hip arthroplasty in patients with rheumatoid arthritis: a 12-year retrospective cohort study of 65,898 patients. J Arthroplasty 35:3517–3523. https://doi.org/10.1016/j.arth.2020.06.085
van der Woude D, van der Helm-van Mil AHM (2018) Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol 32:174–187. https://doi.org/10.1016/j.berh.2018.10.005
Kurtz SM et al (2017) Which clinical and patient factors influence the national economic burden of hospital readmissions after total joint arthroplasty? Clin Orthop Relat Res 475:2926–2937. https://doi.org/10.1007/s11999-017-5244-6
Cordtz R, Odgaard A, Kristensen LE, Overgaard S, Dreyer L (2020) Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: a register-based cohort study from Denmark. Semin Arthritis Rheum 50:30–35. https://doi.org/10.1016/j.semarthrit.2019.06.007
Ravi B et al (2014) Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol 66:254–263. https://doi.org/10.1002/art.38231
Stundner O et al (2014) Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes. J Arthroplasty 29:308–313. https://doi.org/10.1016/j.arth.2013.05.008
Stundner O et al (2013) Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study. Clin Exp Rheumatol 31:889–895
Ravi B et al (2014) Increased surgeon experience with rheumatoid arthritis reduces the risk of complications following total joint arthroplasty. Arthritis Rheumatol 66:488–496. https://doi.org/10.1002/art.38205
Morse KW et al (2020) Tranexamic acid does not reduce the risk of transfusion in rheumatoid arthritis patients undergoing total joint arthroplasty. J Arthroplasty 35:2367–2374. https://doi.org/10.1016/j.arth.2020.04.029
Wilson A, Yu H-T, Goodnough LT, Nissenson AR (2004) Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 116 Suppl 7A:50S-57S
Weber EWG et al (2005) Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 100:1416–1421. https://doi.org/10.1213/01.ANE.0000150610.44631.9D
Stanworth SJ et al (2011) A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 15:R108. https://doi.org/10.1186/cc10129
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232
Gross JB (1983) Estimating allowable blood loss: corrected for dilution. Anesthesiology 58:277–280
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity (2021) World Health Organization: https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.1. Accessed 31 May 2011
Technical specifications of clinical blood transfusion (2001) National health Commission of the People’s Republic of China: http://www.nhc.gov.cn/wjw/gfxwj/200111/2c93606209ec4a25ad9241787f9f7404.shtml. Accessed 8 Nov 2001
Carroll K, Dowsey M, Choong P, Peel T (2014) Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect 20:130–135. https://doi.org/10.1111/1469-0691.12209
Feldmann M, Maini SRN (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223. https://doi.org/10.1111/j.1600-065X.2008.00626.x
Rapala K (1996) The effect of tumor necrosis factor-alpha on wound healing. An experimental study. Ann Chir Gynaecol Suppl 211:1–53
Anstead GM (1998) Steroids, retinoids, and wound healing. Adv Wound Care 11:277–285
Rapala K et al (1997) Tumour necrosis factor-alpha selectivity modulates expression of collagen genes in rat granulation tissue. Eur J Surg 163:207–214
Maish GO, Shumate ML, Ehrlich HP, Vary TC, Cooney RN (1999) Interleukin-1 receptor antagonist attenuates tumor necrosis factor-induced alterations in wound breaking strength. J Trauma 47:533–537
Ismael H et al (2011) Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg 201. https://doi.org/10.1016/j.amjsurg.2010.09.018
Kittle H, Ormseth A, Patetta MJ, Sood A, Gonzalez MH (2020) Chronic corticosteroid use as a risk factor for perioperative complications in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg Glob Res Rev 4:e2000001. https://doi.org/10.5435/JAAOSGlobal-D-20-00001
Boddapati V et al (2018) Preoperative corticosteroid use for medical conditions is associated with increased postoperative infectious complications and readmissions after total hip arthroplasty: a propensity-matched study. Am J Orthop (Belle Mead NJ) 47. https://doi.org/10.12788/ajo.2018.0104
Conroy JL et al (2008) Risk factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty 23:867–872. https://doi.org/10.1016/j.arth.2007.07.009
Khatod M, Barber T, Paxton E, Namba R, Fithian D (2006) An analysis of the risk of hip dislocation with a contemporary total joint registry. Clin Orthop Relat Res 447:19–23
Chevalier T et al (2018) Body mass prediction from femoral volume and sixteen other femoral variables in the elderly: BMI and adipose tissue effects. Am J Phys Anthropol 166:26–42. https://doi.org/10.1002/ajpa.23396
Hastings DE, Parker SM (1975) Protrusio acetabuli in rheumatoid arthritis. Clin Orthop Relat Res. 108:76–83. https://doi.org/10.1097/00003086-197505000-00012
Mibe J, Imakiire A, Watanabe T, Fujie T (2005) Results of total hip arthroplasty with bone graft and support ring for protrusio acetabuli in rheumatoid arthritis. J Orthop Sci 10(1):8–14. https://doi.org/10.1007/s00776-004-0845-9
Zhu TY et al (2015) Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study. Osteoporos Int 26:1759–1771. https://doi.org/10.1007/s00198-015-3077-2
Antoniadis A, Wegrzyn J (2022) Direct cementation of dual mobility cups into the bony acetabulum in primary total hip arthroplasty: clinical and radiographic outcomes at a minimum 5-year follow-up. J Arthroplasty. https://doi.org/10.1016/j.arth.2022.12.031
Ogbemudia AE, Yee SY, MacPherson GJ, Manson LM, Breusch SJ (2013) Preoperative predictors for allogenic blood transfusion in hip and knee arthroplasty for rheumatoid arthritis. Arch Orthop Trauma Surg 133:1315–1320. https://doi.org/10.1007/s00402-013-1784-8
Weiss G, Schett G (2013) Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol 9:205–215. https://doi.org/10.1038/nrrheum.2012.183
Tański W, Chabowski M, Jankowska-Polańska B, Jankowska EA (2021) Iron metabolism in patients with rheumatoid arthritis. Eur Rev Med Pharmacol Sci 25:4325–4335. https://doi.org/10.26355/eurrev_202106_26140
Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD (2002) Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100:474–482
Maury CP, Andersson LC, Teppo AM, Partanen S, Juvonen E (1988) Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis 47:972–978
Grosso MJ et al (2020) The effect of preoperative anemia on complications after total hip arthroplasty. J Arthroplasty 35:S214–S218. https://doi.org/10.1016/j.arth.2020.01.012
Corrado A, Di Bello V, d’Onofrio F, Maruotti N, Cantatore FP (2017) Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis. Int J Immunopathol Pharmacol 30:302–307. https://doi.org/10.1177/0394632017714695
Tsuji H et al (2020) Persistent anemia and hypoalbuminemia in rheumatoid arthritis patients with low serum triiodothyronine level. Mod Rheumatol 30:640–647. https://doi.org/10.1080/14397595.2019.1649109
Zhang S et al (2021) Incidence and risk factors associated with human albumin administration following total joint arthroplasty: a multicenter retrospective study. J Orthop Surg Res 16:643. https://doi.org/10.1186/s13018-021-02642-9
Xu S et al (2019) Blood loss of posterior lumbar interbody fusion on lumbar stenosis in patients with rheumatoid arthritis: a case-control study. Spine (Phila Pa 1976) 44:E1045–E1052. https://doi.org/10.1097/BRS.0000000000003037
Pattison E, Protheroe K, Pringle RM, Kennedy AC, Dick WC (1973) Reduction in haemoglobin after knee joint surgery. Ann Rheum Dis 32:582–584
Erskine JG, Fraser C, Simpson R, Protheroe K, Walker ID (1981) Blood loss with knee joint replacement. J R Coll Surg Edinb 26:295–297
Chen X-X, Wang T, Li J, Kang H (2016) Relationship between inflammatory response and estimated complication rate after total hip arthroplasty. Chin Med J (Engl) 129:2546–2551. https://doi.org/10.4103/0366-6999.192772
Lei Y, Huang Z, Huang Q, Huang W, Pei F (2020) Repeat doses of dexamethasone up to 48 hours further reduce pain and inflammation after total hip arthroplasty: a randomized controlled trial. J Arthroplasty 35:3223–3229. https://doi.org/10.1016/j.arth.2020.06.023
Acknowledgements
We gratefully acknowledge the surgeons from Department of Orthopedics of West China Hospital. All authors have read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital of Sichuan University (Date May 11, 2021/No.2022–748).
Consent to participate
Written informed consent from participants was not required because the study was retrospective and analyzed anonymized data with no risk to the patients.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Wenyu Jiang, Hong Xu, and Xing Wang are co-first authors; these three authors contributed to this article equally.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, W., Xu, H., Wang, X. et al. More complications and higher transfusion rate in patients with rheumatoid arthritis than osteoarthritis undergoing total hip arthroplasty. International Orthopaedics (SICOT) 47, 1189–1196 (2023). https://doi.org/10.1007/s00264-023-05728-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-023-05728-7